VEGFA and amyloidosis: Interestingly, the most potent vascular permeability factor, vascular endothelial growth factor (VEGF), has previously been implicated in AD and CAA pathology, such that selectively inhibiting three of its receptors resulted in decreased amyloid deposition in vessels and decreased glial reactivity(50).